2 Taiwan hospitals start mix-and-match trials with local COVID vaccine

Two hospitals in Taiwan are conducting trials in which the participants receive one dose of either the AstraZeneca or Moderna COVID-19 vaccine and then the locally made Medigen as a second shot, the developer said Tuesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)